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Cardiovascular disease is the most common cause of death in
patients with end-stage renal disease, possibly due to a
specific ‘uremic cardiomyopathy’. This study investigated the
function of the Naþ /Ca2þ exchanger in single cardiac
myocytes from a model of early renal impairment. Mild
uremia was induced by partial (5/6) nephrectomy in male
Wistar rats. After 4 weeks, ventricular myocytes were isolated,
loaded with the fluorescent Ca2þ indicator indo-1, and
contractile function and calcium transients recorded
following electrical pacing at 0.2 Hz. Relaxation from rapid
cooling contractures (RCCs) was also studied. Cells from
uremic animals (U) were hypertrophied compared with
controls (C), with a significant increase in width (14%;
Po0.02) and cross-sectional area (13%; Po0.03). There was a
significant increase in diastolic intracellular Ca2þ ratio in the
uremic cells (C, 0.3370.00 vs U, 0.3770.02; Po0.02),
although the amount of calcium released per twitch was
similar. Uremic cells were slower to relax following RCCs,
however when Naþ /Ca2þ exchange was inhibited using a
Naþ -free/Ca2þ -free solution, this difference was abolished.
Under these conditions, there was little difference in the
relaxation rate of control cells, indicating that the Naþ /Ca2þ
exchanger plays only a minor role in relaxation in normal rat
myocytes. However in uremia, the data indicate that the
Naþ /Ca2þ exchanger actively interfered with relaxation,
possibly by working in reverse rather than forward mode.
These results indicate that myocyte relaxation and Ca2þ
handling are abnormal in early uremia and may provide
further evidence for the existence of a specific ‘uremic
cardiomyopathy’.
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In end-stage renal failure the most common cause of death is
cardiovascular disease.1,2 Over 50% of patients with end-
stage renal failure die prematurely from cardiovascular
causes, despite receiving adequate renal replacement therapy.
Of particular significance is the finding that cardiac disease is
especially prevalent. The risk of death from a myocardial
infarction has been shown to be consistently 18–20 times that
of the general population, whatever a particular population’s
inherent risk may be.1 It is clear that genetic and
environmental factors may not be held accountable and that
uremia itself amplifies the risk of cardiac disease in a specific
manner. It is therefore important to understand whether
uremic cardiac disease is a discreet entity or if heart disease
per se is accelerated in these patients.
In several animal models of cardiac failure, the level
of diastolic intracellular Ca2þ ([Ca2þ ]i) in single cardiac
myocytes has been found to be altered, whereas in others
it is reputedly unchanged. For example, in rats with
experimentally induced ischemic heart disease it has
been reported that diastolic Ca2þ is elevated after 7 days,3
whereas in the rat model of diabetic cardiomyopathy it is
apparently reduced.4 In hypertrophied cells isolated from
the spontaneously hypertensive rat, contraction amplitude
is increased compared with control cells5 and the size of
the calcium transient is greater than normal with no change
in diastolic [Ca2þ ]i.
6 This was found to be due to increased
action potential duration, leading to an increased amount of
calcium being stored in the sarcoplasmic reticulum (SR).
Diastolic dysfunction is commonly found in end-stage
renal failure patients and both clinical and experimental
evidence suggest that myocardial damage occurs early in the
course of the disease.7–9 We have previously reported
impaired contractile function in cardiac myocytes isolated
from animals after 4 weeks of experimental uremia.8 In
addition, we have also described a prolongation of the Ca2þ
transient under experimental conditions of increased extra-
cellular Ca2þ .9 In the present study, we report for the first
time simultaneous [Ca2þ ]i and contractile function mea-
surements from single uremic cardiac myocytes and assess
the function of the Naþ /Ca2þ exchanger and its contribu-
tion to the impaired relaxation of these cells.
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RESULTS
Blood biochemistry
Both urea and creatinine were significantly increased in the
5/6 nephrectomy group as expected (urea 7.370.4 mmol l1
in control animals, C vs 23.171.9 mmol l1 in uremic
animals, U, Po0.0001; creatinine 6070 mmol l1, C vs
150710 mmol l1 U, Po0.0001).
Cell morphology
There was no difference in the mean length of uremic
myocytes compared with control myocytes (Figure 1a) but
there was a 14% increase in width (Po0.02; Figure 1b) and a
13% increase in two-dimensional area (Po0.03; Figure 1c)
indicating significant hypertrophy. There was no change in
cell perimeter (C, 24274mm vs U, 25276 mm; NS) or form
factor (C, 0.5270.01 vs U, 0.5370.01; NS) between the
groups.
Intracellular Ca2þ transient ratios
There was a significant increase in diastolic [Ca2þ ]i ratio in
the uremic cells (C, 0.3370.00 vs U, 0.3770.02; Po0.03;
Figure 2a). Systolic [Ca2þ ]i ratios appeared to be similarly
elevated, but this was not statistically significant. The change
in fluorescence ratio (i.e. the difference between diastolic and
systolic fluorescence) was almost identical between the
groups (Figure 2b).
Measurement of contractile parameters
Twitch amplitude. Twitch amplitude (% change in cell
length) was similar in control and uremic cells (C,
10.670.9% n¼ 29 vs U, 9.971.2%, n¼ 31; NS).
Twitch amplitude/RCC. The relative amplitudes of twitches
and rapid cooling contracture (RCCs) were compared for
each cell. Twitch amplitude was expressed as a percentage of
the RCC amplitude, and there was no difference between the
groups suggesting that qualitatively similar amounts of Ca2þ
were released for a given SR Ca2þ content in control and
uremic cells.
Double RCCs in normal Tyrode solution
There was no difference between uremic and control cells
with respect to the ratio of RCC2/RCC1 amplitudes in
normal Tyrode solution (NT). A similar proportional change
in amplitude (indicating similar amounts of Ca2þ lost via
sarcolemmal mechanisms) occurred in each group (C,
1473%, n¼ 13 vs U, 1872%, n¼ 16; NS). This finding
implies that, in both uremic and control rat cardiac
myocytes, over 80% of relaxation is brought about by SR-
dependent mechanisms.
Effect of manipulation of re-warming solutions on cell
relaxation and removal of cytosolic Ca2þ
The effect of manipulation of the re-warming solutions on
cell relaxation is shown in Figure 3a and b. Uremic cells were
significantly slower to reach 50 and 80% relaxation when re-
warmed in NT compared with control cells (Figure 3a). The
90% value fell just outside statistical significance (P¼ 0.056),
possibly as a result of the large spread of data points in
the uremic group. When re-warmed in 0Na/0Ca solution,
however, there was no longer a difference between the groups
(Figure 3b). This suggests that the Naþ /Ca2þ exchanger
affects relaxation in the uremic cells (Figure 4).
Effect of cell size on [Ca2þ ]i kinetics and contractility
Data are presented as box and whisker plots displaying the
median values and the 25th and 75th percentiles. Despite a
statistically significant difference in cell width (18.8571.89 vs
30.7773.08, Po0.0001), there was no difference in time to
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Figure 1 | Cell morphology. (a) Cell length was not different
between the C (n¼ 54) and U (n¼ 56) groups, (b) although U cells
were significantly wider, **Po0.02. (c) There was a significant
increase in U cell area compared with C (**Po0.03). Values are
mean7s.e.
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Figure 2 | Intracellular Ca2þ transient ratios. (a) Diastolic and
systolic [Ca2þ ]i ratios in C (& n¼ 35) and U (’, n¼ 37) cells,
**Po0.03. (b) Mean amplitude of the Ca2þ transient during electrical
pacing in C and U cells.
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Figure 3 | Relaxation characteristics. (a) Times to 50, 80, and 90%
relaxation in NT following an RCC in C (&) and U (’) cells, *Po0.03.
(b) Times to 50, 80, and 90% relaxation in 0Na/0Ca following an RCC
in C (&) and U (’) cells.
Kidney International (2006) 69, 846–851 847
A C McMahon et al.: Naþ /Ca2þ exchanger dysfunction in uremic cardiac myocytes o r i g i n a l a r t i c l e
peak [Ca2þ ]i (TTP, Figure 5a) or in time to 50 or 90%
restoration of diastolic [Ca2þ ]i (R50, R90, Figure 5b)
indicating that cell width had no effect on Ca2þ kinetics.
Similarly, despite a statistically significant difference in cell
length (92.5279.25 mm vs 109.00710.90mm, Po0.0001),
there was no difference in TTP [Ca2þ ]i (Figure 5c) or in R50
or R90 (Figure 5d) indicating that cell length had no effect on
Ca2þ kinetics.
DISCUSSION
The biochemical changes induced by the 5/6 nephrectomy
technique were consistent with a moderate degree of renal
impairment. The data presented demonstrate clear evidence
of ventricular hypertrophy at the cellular level in early
uremia. This supports our earlier finding of left ventricular
hypertrophy in this model in the absence of hypertension.9
Elevation of diastolic [Ca2þ ]i implies an impairment of
some cellular homeostatic mechanism(s) concerned with
Ca2þ regulation. In uremia, it is well established that serum
ionised [Ca2þ ] is reduced due primarily to renal phosphate
retention,10 which, in turn, leads to increased production of
parathyroid hormone and mobilization of Ca2þ from bone.
Myocardial calcium content in dialysis patients is greater
than in control subjects and has been strongly associated with
myocardial dysfunction.11 We12 and others13 have previously
reported that platelet [Ca2þ ]i is elevated in uremia and it is
therefore possible that the cardiac myocyte membrane Ca2þ
gradient has also been re-set. Re-setting of this gradient is
known to occur in other forms of cardiac disease, although it
has not previously been reported in uremia. For example, in
experimental diabetes, cardiac myocyte [Ca2þ ]i has been
reported to be reduced compared with control values,4
whereas in a rat model of ischemic heart disease induced by
coronary artery narrowing it is significantly increased after 7
days.3 The mechanism(s) that may underlie the change in
diastolic [Ca2þ ]i are not known. However, parathyroid
hormone has been demonstrated to inhibit the Naþ /Kþ
pump in rat proximal tubule14 and activate the cardiac
isoform of the Naþ /Hþ exchanger.15 In cardiac myocytes, an
increase in [Naþ ]i brought about by either of these routes
could alter the function of the Naþ /Ca2þ exchanger and so
lead to changes in [Ca2þ ]i.
The potential implications of this finding in early uremia
must be considered, as it is well known that cellular Ca2þ
overload can ultimately result in cell death. Additional
complications of cellular Ca2þ overload in cardiac cells are
altered contractile function and cardiac arrhythmias. One of
the known causes of Ca2þ overload is a reduction in energy
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Figure 4 | Sample length traces from one control and one uremic
cell showing relaxation from an RCC with re-warming in NT (top)
and 0Na/0Ca solution (bottom).
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Figure 5 | (a and b) Effect of cell width on (a) time to peak [Ca2þ ] and (b) time to 50 and 90% restoration of diastolic [Ca2þ ]. (c and d)
Effect of cell width on (c) time to peak [Ca2þ ] and (d) time to 50 and 90% restoration of diastolic [Ca2þ ].
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availability to maintain normal ionic gradients.16 We have
also shown in a similar model of experimental uremia that
there is a reduced myocardial energy supply, with reductions
in phosphocreatine (PCr) and PCr/ATP ratio.17 In addition,
in control hearts, cardiac output increased with increasing
perfusate [Ca2þ ] whereas uremic hearts failed in high
calcium perfusate. Although the level of uremia was greater
in this study with approximately a fourfold increase in
plasma urea and creatinine above control values, and a
shorter time course (3 weeks), this may well at least partially
explain the results reported here.
We have previously demonstrated that the RCC technique
releases all Ca2þ stored in the SR, similarly to the rapid
application of caffeine.18 It has been used in models of
hypertrophy 19 and heart failure20 to demonstrate indicators
of diastolic dysfunction, but never previously in the context
of uremia. We have also previously shown that cell size per se
does not influence the contractile or Ca2þ regulatory
properties of cardiac myocytes by comparing the relaxation
phases of the 25% smallest and 25% largest cells from a
control population.19 In the present study, we provide
additional information in support of this earlier finding by
comparing narrow vs wide cells and short vs long cells from
control animals (Figure 5). No differences were observed in
any of the parameters of Ca2þ handling measured such that
changes in relaxation characteristics may be attributed to the
manifestation of uremic injury independently of changes in
cell size.
A comparison of twitch amplitude expressed as a
percentage of RCC amplitude revealed no differences between
control and uremic cells. This suggests that a similar amount
of stored Ca2þ was released from the SR per twitch in each
group. Also, in NT, a comparable amount of Ca2þ appears to
be lost during the relaxation phase in each group, as
indicated by the similarity of the RCC2 amplitude/RCC1
amplitude data.
The experiments involving selective inhibition of
Naþ /Ca2þ exchange during relaxation show very
apparent differences between control and uremic cells:
under control conditions, relaxation time was increased
in uremic cells (Figure 4a); however, when Naþ /Ca2þ
exchange was inhibited, uremic cells relaxed as fast as
control cells (Figure 4b). This suggests that in uremia,
Naþ /Ca2þ exchange actively interferes with the process of
relaxation.
Rat ventricular myocytes have higher [Naþ ]i compared
with rabbit for example.21 Therefore, during the diastolic
phase, the reversal potential of the Naþ /Ca2þ exchanger is
brought close to the diastolic membrane potential, which
dictates that there will be very little outward movement of Ca
(or inward Naþ /Ca2þ exchange current). The role played by
the exchanger in relaxation in rat cardiac myocytes is
therefore small compared with its role in rabbit heart cells.22
This is demonstrated by our data in Figure 3, where in
control cells, the inhibition of Naþ /Ca2þ exchange made
little difference to relaxation.
In uremia it is reasonable to speculate that [Naþ ]i will
increase in the heart. As mentioned previously, [Naþ ]i has
been demonstrated to inhibit the Naþ /Kþ pump in rat
proximal tubule14 and activate the cardiac isoform of the
Naþ /Hþ exchanger.15 Since the transmembrane Naþ
gradient affects the function of the sarcolemmal Naþ /Ca2þ
exchanger, any increase in [Naþ ]i will bring the reversal
potential of the Naþ /Ca2þ exchanger more negative than the
diastolic membrane potential and produce Ca2þ influx. Even
a 1–2 mM increase in [Naþ ]i would shift the reversal potential
below the membrane potential and cause a consistent inward
movement of Ca2þ (outward exchange current) during most
of the diastolic period. This effect has been described in rat
ventricle, where net Ca2þ extrusion occurs during systole
and net Ca2þ gain during diastole.21 Ca2þ entering the cell
via the exchanger raises resting (diastolic) Ca2þ and loads
the SR. The effect is demonstrated by an increase in
contraction amplitude following a period of rest.23
The foregoing provides a reasonable explanation for the
increase in relaxation time in uremic cells. If [Naþ ]i is greater
in these cells, the Naþ /Ca2þ exchanger will produce more
Ca2þ entry during relaxation than in control cells, tending to
slow relaxation. When Naþ /Ca2þ exchange is inhibited (in
Naþ -free, Ca2þ -free solution), uremic cells relax as fast as
control cells (Figure 4b) because Ca2þ entry is inhibited. It is
likely that subsarcolemmal [Naþ ] determines exchanger
function and this concentration may be different from the
cytoplasmic [Naþ ] given the putative diffusional barrier that
may produce the so-called ‘fuzzy space’.24,25 The extent of
subsarcolemmal [Naþ ] changes in the present model of
uremia remain essentially unquantifiable and may be
distinctly different from (‘global’) cytoplasmic [Naþ ].
Initially, these results appear to slightly contradict the
double RCC data, which clearly show that some Ca2þ is lost
from both groups of cells during relaxation. It is likely that
the involvement of other Ca2þ regulatory mechanisms has a
more noticeable effect under these circumstances. A likely
candidate is the sarcolemmal Ca-ATPase system, which is a
slow extruder of Ca2þ . Under normal conditions this has a
relatively small capacity, removing less than 1% of the total
Ca2þ released in a normal twitch.22 Following a RCC,
however, there is an excessive amount of Ca2þ present
relative to a normal twitch, such that a more significant
fraction may be removed via this route.
The use of Naþ /Ca2þ exchanger inhibition in the manner
described also provides some information about SR function.
Although the relaxation time of the control cells was not
affected by either condition, the relaxation time of the uremic
cells was significantly improved (reduced) during inhibition
of the exchanger, to such an extent that it was no longer
different from control values. This implies that SR function is
not impaired. This point is clearly demonstrated in Figure 4b
in which relaxation times of control and uremic cells during
inhibition of Naþ /Ca2þ exchange are identical.
The exchanger is known to be affected by factors other
than the extracellular and intracellular concentrations of
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Naþ and Ca2þ . For example, a reduction in intracellular pH
has an inhibitory effect on the exchanger.26,27 However,
although chronic renal failure is often associated with
acidosis, we have previously reported no change in plasma
bicarbonate levels in this model.9
In summary, although no direct measurements of
Naþ /Ca2þ exchange current have been made in these
experiments, evidence suggests that in control cells it makes
little contribution to relaxation and in uremic cells it acts to
slow the process. This most likely occurs due to a raised
[Naþ ]i though more direct measurements are required to
test this hypothesis.
From these data alone it appears that the characteristics of
uremic cardiac cells are different from those of other models
of heart failure, particularly as SR function is maintained. In
most other models of heart failure, SR function is reduced,
although it is important to remember that the individual
features of any progressive disease model are likely to be
characteristic of a particular stage of the disease process.
These data support the presence of a specific uremic
cardiomyopathy, although further investigations are required
for validation of this suggestion.
MATERIALS AND METHODS
Experimental animals
Male Wistar rats (200–220 g) underwent 5/6 nephrectomy (U, n¼ 5)
or sham-operation (C, n¼ 5) in a two-stage surgical procedure that
has been described in detail elsewhere.8 Briefly, under general
anesthesia two-thirds of the left kidney was removed, followed 1
week later by removal of the right kidney. Sham-operated control
animals had each kidney decapsulated and replaced intact 1 week
apart. Animals were housed singly, with each control being pair-fed
with a uremic partner to ensure similar body weight changes during
the experiment. Water was available ad libitum.
Isolation and indo-1 loading of cardiac myocytes
Four weeks after the completion of surgery, cardiac myocytes were
isolated as previously described.8 Myocytes from the left and right
ventricles were pooled. Cells were placed in Dulbecco’s modified
Eagle’s medium and loaded with indo-1/AM (5mM final concentra-
tion) in the dark for 20 min. The supernatant was removed and the
cells resuspended in fresh Dulbecco’s modified Eagle’s medium.
Cell morphology
Images of a number of cells (nX54) from each preparation were
obtained using a video graphic printer (UP-860CE, Sony), thereby
allowing a representative analysis of the single-cell morphology of
each ventricular preparation. Length (L), width (W), area (A),
perimeter (P), and form factor were recorded. The form factor is an
indication of how closely a particular shape approximates to a circle
(value¼ 1). This allows cells that have started to round up
irreversibly to be excluded from the analysis.
Measurement of intracellular Ca2þ and contraction
Intracellular Ca2þ monitoring and changes in cell length were
carried out as previously described.19,28 Cells were placed in a
shallow superfusion chamber after the addition of 5 ml mouse
laminin (Sigma) to promote adhesion, and allowed to attach for
5 min before superfusion was initiated. Superfusion fluid was NT
(containing in mM: NaCl 140; KCl 6; MgCl2 1; CaCl2 2; glucose 10;
N-2-hydroxyethylpiperazine-N0-2-ethanesulfonic acid 10; pH 7.4 at
room temperature). Flow rate was 2 ml/min and the electrical field
stimulation rate was 0.2 Hz. The cell under study was illuminated
with red light (4580 nm) and the image projected to a video edge-
detection system for cell length measurements. Background
fluorescence was removed. The ratios of indo-1 fluorescence were
not quantified but used as qualitative indicators of changes in
intracellular free Ca2þ concentration ([Ca2þ ]i). Experiments were
conducted at room temperature.
Generation of a RCC
Background to the technique. The RCC technique is a useful
method for quantifying the relative contributions of SR-dependent
and SR-independent mechanisms to cardiac cell relaxation. The
rapid cooling of a cardiac myocyte from room temperature to 11C in
less than a second is known to cause the SR to empty its store of
Ca2þ into the cytoplasm, thereby bringing about a contracture.29
Cooling greatly increases the open probability of the SR Ca2þ
release channel so a large efflux of Ca2þ occurs from the SR. The
contracture is maintained while the cell is cooled because the major
Ca2þ removal mechanisms are essentially suppressed at this
temperature. Suppression is removed by re-warming the cell back
to room temperature and the cell relaxes. This technique was used to
investigate the contribution of the Naþ /Ca2þ exchanger to
relaxation in control and uremic cardiac myocytes. The function
of Naþ /Ca2þ exchange in mammalian cardiac cells is usually to
expel Ca2þ , using the energy derived from the trans-sarcolemmal
Naþ gradient. However, the direction of ion movement on the
Naþ /Ca2þ exchanger is dependent on membrane potential, the
extracellular and the intracellular concentrations of Naþ and Ca2þ .
The potential at which ion movement switches direction is called the
reversal potential. The reversal potential is readily encountered
under physiological conditions and can be changed by small changes
in [Naþ ]i. Thus, the efflux of Ca
2þ from the cell is very dependent
on [Naþ ]i. Na
þ /Ca2þ exchange was selectively inhibited during
relaxation by using Naþ -free/Ca2þ -free (0Na/0Ca) solution during
the re-warming phase. In this situation Naþ /Ca2þ exchange
function is prevented, so relaxation occurs independently of this
Ca2þ -regulatory protein. 0Na/0Ca solution composition was the
same as NT, but NaCl was substituted by equimolar addition of LiCl,
and 0.75 mM ethylenediaminetetraacetic acid (Sigma) was added; no
CaCl2 was added (pH 7.4).
Producing RCCs. The methods used have been described in
detail elsewhere.19,29 Briefly, several steady-state twitches were
recorded from a selected cell. After a rest period of 10 s, the cell
was rapidly cooled to 11C in less than a second, thereby causing it to
contract. Cooling was effected using a series of solenoid valves (Lee
Products Ltd, Gerards Cross, UK) positioned at the point of fluid
influx to the chamber. The fluid reservoir was placed in a water
circulator (model LTD6, Grant Instruments Ltd., Cambridge)
containing a water/ethylene glycol mixture (4:1) maintained at
3.51C. NT was gravity-fed to the superfusion chamber along
jacketed tubes that also contained the cooling mixture to minimize
warming during the passage of solution from reservoir to cell. The
flow rate of the cooled superfusate was 12–15 ml/min to ensure a
rapid change in cell temperature. Following a RCC, the cells were re-
warmed in either NT or 0Na/0Ca solution. Cells were only
superfused for a short time (seconds) in 0Na/0Ca solution in order
to avoid marked changes in intracellular ion concentrations.
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Double RCC technique. Further data regarding Ca2þ fluxes
and SR stores were obtained using paired RCCs. When a cell is
subjected to rapid cooling (RCC1) and is re-warmed in NT, some
Ca2þ is extruded and the rest taken up by the SR. At this point, the
cell has incurred a net loss of Ca2þ . By initiating a second RCC
(RCC2) without intervening stimulation this Ca2þ loss may be
estimated as a percentage of the amplitude of RCC1. If only NT is
used, the second RCC will be smaller than the first, the extent of the
difference being dependent upon the contributions played by
various Ca2þ efflux mechanisms that, in turn, vary in importance
between species.22
Data acquisition and processing
Signals were stored directly onto magnetic tape and later transcribed
into short individual data files using Axotape software version 2.0
(Axon Instruments Inc., Foster City, CA). From each file, four
consecutive transients were signal averaged. From the end of the
transient, the resting fluorescence was recorded in ratio units as a
measure of the diastolic [Ca2þ ]i. Peak (systolic) [Ca
2þ ]i after
stimulation was also recorded, and the increment in fluorescence
calculated.
For RCC data, the amplitude of the RCC was measured and
compared with twitch amplitude. The measurements were taken
from the top of the re-warming spike to 50, 80, and 90% recovery of
resting cell length. The re-warming spike is due to increased
myofilament sensitivity rather than additional Ca2þ release.29 Cells
failing to relax completely were excluded from the study. Measure-
ments were taken from individual RCC traces rather than averaged
data, although the twitch data were the average of at least four
consecutive contractions.
Effect of cell size on [Ca2þ ]i kinetics and contractility
In order to ascertain the independence of changes in Ca2þ kinetics
and, therefore, contractility from cell size per se, additional data were
obtained from control animals. For these comparisons, the 10
narrowest cells were compared directly with the 10 widest cells and,
similarly, the shortest cells compared with the longest.
Statistical analysis
Data are presented as mean7s.e., where n¼ number of cells studied,
except where otherwise stated. Student’s t-test (two-tailed) was used
to compare the significance of the difference between the means for
normally distributed data. A value of Po0.05 was taken to indicate a
significant difference between the groups.
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